Common factors such as education, ethnicity, income, and marital status do not appear to be risk factors for the development of MDD. Instead, MDD often emerges subsequent to a significant ...

Although there are many potential treatment modalities for MDD ... demonstrated greater efficacy for select subgroups of depressive disorders, a topic that is beyond the scope of this article.

These approaches help individuals identify and change negative thought patterns, develop coping strategies, and address underlying issues ... help and foster a more supportive environment for ...

Early effective treatment strategies can have a significant ... contributors to long-term outcomes for patients with major depressive disorder.

An increase in the global prevalence and burden of depression has been consistently ... in clinical studies for the treatment of MDD is implicated as a major reason for the failure of clinical ...

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

Cybin launches Phase 3 trials for CYB003, aiming to offer lasting relief for Major Depressive Disorder. Backed by promising ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can ...

Generalized anxiety disorder (GAD) and major ... depression. You don't need an official anxiety or depression diagnosis to ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in ... and then go over treatment options and coping strategies. Bipolar I is thought to be the most common ...